
P&G Health Q2 FY27: Standalone PAT Up 26% YoY to ₹111.5 Cr, Margins Expand, Tops Own Preview Range
pharmaceuticals · margin expansion · standalone results
BSE: 500126
P/L Snapshot
Q2 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)

pharmaceuticals · margin expansion · standalone results

margin pressure · raw material costs · growth deceleration

pharmaceuticals · one-off gain · asset sale
Corporate Events
Board Meeting
A meeting of the Board of Directors of the Company is schedu…
BSE Filing ↗Board Meeting
The 59th Annual General Meeting of the Company is scheduled …
BSE Filing ↗Board Meeting
The meeting of the Board of Directors of the Company is sche…
BSE Filing ↗Board Meeting
The Board of Directors approved the Unaudited Financial Resu…
BSE Filing ↗Board Meeting
To consider and approve Audited Financial Statements for the…
BSE Filing ↗Board Meeting
Update on board meeting, declaration of interim dividend for…
BSE Filing ↗Board Meeting
Update on board meeting, consider declaration of interim div…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results for the Qua…
BSE Filing ↗Board Meeting
Considering and approving Audited Financial Results and Stat…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results for the Qua…
BSE Filing ↗Board Meeting
Consideration and approval of unaudited Financial Results fo…
BSE Filing ↗Board Meeting
Consider and approve the Unaudited Financial Results for the…
BSE Filing ↗